387 related articles for article (PubMed ID: 30616330)
21. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
[TBL] [Abstract][Full Text] [Related]
22. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
Chuang CP; Jong YS; Wu CY; Lo HM
Am J Cardiol; 2014 Mar; 113(5):845-50. PubMed ID: 24406111
[TBL] [Abstract][Full Text] [Related]
23. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
24. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
JACC Heart Fail; 2016 Sep; 4(9):736-45. PubMed ID: 27395353
[TBL] [Abstract][Full Text] [Related]
25. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
26. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
27. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
28. Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
Stienen S; Salah K; Moons AH; Bakx AL; van Pol PE; Schroeder-Tanka JM; Voogel AJ; Keijer JT; Kortz RA; Dickhoff C; Meregalli PG; Tijssen JG; Pinto YM; Kok WE
Am Heart J; 2014 Jul; 168(1):30-6. PubMed ID: 24952857
[TBL] [Abstract][Full Text] [Related]
29. Predicting short-term mortality in advanced decompensated heart failure - role of the updated acute decompensated heart failure/N-terminal pro-B-type natriuretic Peptide risk score.
Scrutinio D; Ammirati E; Passantino A; Guida P; D'Angelo L; Oliva F; Ciccone MM; Iacoviello M; Dentamaro I; Santoro D; Lagioia R; Sarzi Braga S; Guzzetti D; Frigerio M
Circ J; 2015; 79(5):1076-83. PubMed ID: 25753469
[TBL] [Abstract][Full Text] [Related]
30. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality.
Bayés-Genís A; Lopez L; Zapico E; Cotes C; Santaló M; Ordonez-Llanos J; Cinca J
J Card Fail; 2005 Jun; 11(5 Suppl):S3-8. PubMed ID: 15948093
[TBL] [Abstract][Full Text] [Related]
31. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
[TBL] [Abstract][Full Text] [Related]
32. Gender Difference in the Prognostic Value of N-Terminal Pro-B Type Natriuretic Peptide in Patients With Heart Failure - A Report From the Korean Heart Failure Registry (KorHF).
Kim HL; Kim MA; Choi DJ; Han S; Jeon ES; Cho MC; Kim JJ; Yoo BS; Shin MS; Seong IW; Ahn Y; Kang SM; Kim YJ; Kim HS; Chae SC; Oh BH; Lee MM; Ryu KH;
Circ J; 2017 Aug; 81(9):1329-1336. PubMed ID: 28442636
[TBL] [Abstract][Full Text] [Related]
33. New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis.
Baggish AL; van Kimmenade RR; Pinto Y; Richards AM; Lainchbury J; Bayes-Genis A; Santaló M; Ordonez-Llanos J; Januzzi JL
Biomarkers; 2010 Jun; 15(4):307-14. PubMed ID: 20370326
[TBL] [Abstract][Full Text] [Related]
34. Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure.
Zhang J; Pellicori P; Pan D; Dierckx R; Clark AL; Cleland JGF
Int J Cardiol; 2018 Oct; 269():196-200. PubMed ID: 30001941
[TBL] [Abstract][Full Text] [Related]
35. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
36. NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies.
Luers C; Sutcliffe A; Binder L; Irle S; Pieske B
Clin Biochem; 2013 Aug; 46(12):1013-1019. PubMed ID: 23542086
[TBL] [Abstract][Full Text] [Related]
37. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
38. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
[TBL] [Abstract][Full Text] [Related]
39. The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure.
Dai Z; Asano T; Takahashi O; Komiyama N; Ohde S
BMC Cardiovasc Disord; 2020 Jun; 20(1):262. PubMed ID: 32487160
[TBL] [Abstract][Full Text] [Related]
40. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
